Clinical Outcome in Patients with Intermediate Stenosis of Left Anterior Descending Coronary Artery after Deferral of Revascularization on the Basis of Noninvasive Coronary Flow Reserve Measurement

Background: Several reports suggest that noninvasive measurements of coronary flow reserve (CFR) by use of echocardiography may support decision making in intermediate stenosis of the left anterior descending coronary artery (LAD). The aim of the present study was therefore to analyze the clinical outcome in patients with intermediate stenosis of LAD after deferral of coronary revascularization on the basis of noninvasive CFR measurement. Methods: the study population included 280 patients with intermediate LAD stenosis (50–70% by angiography) (62.2 ± 9.6 years). All the patients underwent transthoracic CFR assessment of LAD (after dipyridamole infusion) within 2 weeks from coronary angiography. If CFR of LAD was ≤ 2, PTCA was recommended; if CFR was > 2, medical treatment was chosen. Primary end points were cardiac death, myocardial infarction, coronary revascularization procedure, and unstable angina. Results: mean follow‐up was 43 ± 11 months (range 12–52 months). In 150 patients (53.6%) (CFR ≤ 2), coronary artery revascularization was performed (PTCA group); the remaining 130 patients (46.4%) (CFR > 2) were medically treated (medical group). Survival from cardiac death was 94% in the PTCA group and 92.4% in the medical group (P = 0.56). As for all cardiac events, the Kaplan–Meier percentage survival from cardiac events was 88.3% in the PTCA group and 86.4% in the medical group (P = 0.36). Conclusions: even if CFR as a “stand‐alone” diagnostic criterion suffers from several structural limitations, a combined strategy including also other clinical and instrumental measurements before undergoing interventional procedures could improve the cost–benefit practice, in particular, for the management of patients with intermediate LAD stenosis.

[1]  E. Picano,et al.  Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter. , 2007, The American journal of cardiology.

[2]  Maria Siebes,et al.  Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. , 2006, Circulation.

[3]  M. Galderisi,et al.  Coronary flow reserve evaluation in stress-echocardiography laboratory. , 2006, Journal of cardiovascular medicine.

[4]  T. Holland-Letz,et al.  Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. , 2006, American heart journal.

[5]  E. Picano,et al.  The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. , 2006, European heart journal.

[6]  J. Zamorano,et al.  Prognosis of coronary flow reserve: a new therapeutic target? , 2006, European heart journal.

[7]  B. Tuccillo,et al.  Incremental diagnostic value of ultrasonographic assessment of coronary flow reserve with high-dose dipyridamole in patients with acute coronary syndrome. , 2006, International journal of cardiology.

[8]  J. Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Circulation.

[9]  A. Raviele,et al.  The additional prognostic value of coronary flow reserve on left anterior descending artery in patients with negative stress echo by wall motion criteria. A Transthoracic Vasodilator Stress Echocardiography Study. , 2006, American heart journal.

[10]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Journal of the American College of Cardiology.

[11]  C. de Gregorio Coronary flow reserve in dilated cardiomyopathy: an important pathophysiological tool to be considered among, but not instead of, other well-established prognostic factors. , 2006, European heart journal.

[12]  F. Schiele,et al.  One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. , 2005, European heart journal.

[13]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  E. Picano,et al.  Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study. , 2005, International journal of cardiology.

[15]  M. Galderisi,et al.  The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography , 2005, Cardiovascular ultrasound.

[16]  F. Rigo Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool , 2005, Cardiovascular Ultrasound.

[17]  P. Vardas,et al.  Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[18]  F. Romeo,et al.  Coronary flow: a new asset for the echo lab? , 2004, European heart journal.

[19]  K. Ohtomo,et al.  Impaired myocardial vasodilatation during hyperaemic stress is improved by simvastatin but not by pravastatin in patients with hypercholesterolaemia. , 2004, European heart journal.

[20]  I. Olivotto,et al.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[21]  R. Cannon Assessing risk in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[22]  M. Takeuchi,et al.  Simultaneous assessment of wall motion and coronary flow velocity in the left anterior descending coronary artery during dipyridamole stress echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  B. Meier,et al.  Interventional cardiology in Europe 1999. , 1996, European heart journal.

[24]  P. Serruys,et al.  Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome , 2002, Circulation.

[25]  J. Tijssen,et al.  Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. , 2002, The American journal of cardiology.

[26]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[27]  William Wijns,et al.  Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial , 2001, Circulation.

[28]  D. Hildick-Smith,et al.  Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study. , 2000, Journal of the American College of Cardiology.

[29]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[30]  S. Iliceto,et al.  Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. , 1999, Journal of the American College of Cardiology.

[31]  S. Windecker,et al.  Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. , 1999, European heart journal.

[32]  E. Picano,et al.  Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies. , 1998, Journal of the American College of Cardiology.

[33]  D. Baim,et al.  Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. , 1998, Journal of the American College of Cardiology.

[34]  M. Kern,et al.  From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. , 1997, Journal of the American College of Cardiology.

[35]  E. Topol,et al.  Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. , 1995, Circulation.

[36]  S. M. Collins,et al.  Visual estimates of percent diameter coronary stenosis: "a battered gold standard". , 1988, Journal of the American College of Cardiology.

[37]  C. White,et al.  Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? , 1984, The New England journal of medicine.

[38]  F. Tristani,et al.  Left main coronary artery stenosis: angiographic determination. , 1983, Circulation.

[39]  L D Fisher,et al.  Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS). , 1982, Catheterization and cardiovascular diagnosis.